Table 1 Clinicopathologic parameters of 21 women with invasive breast cancer

From: Immunohistochemical detection of Ki67 in breast cancer correlates with transcriptional regulation of genes related to apoptosis and cell death

Case No.

Age (years)

Tumor size (cm)

Grade

Mitoses (per 10 hpf)

Mitotic score

LVI

LN stage

ER

PR

CerbB2

Ki67 (%)

 1

53

4

3

13

3

Pres

1

2+

40

 2

67

2

3

27

3

Pres

3

2+

40

 3

51

5

3

19

3

Abs

2

3+

40

 4

60

4.1

3

30

3

Abs

1

3+

60

 5

56

1.2

2

1

1

Abs

NA

3+

30

 6

48

6

3

15

3

Abs

1

0

20

 7

51

3.5

2

14

3

Abs

2

+

+

0

30

 8

43

6

3

23

3

Pres

3

+

0

90

 9

57

4.5

3

11

3

Pres

3

0

75

10

40

3.5

3

12

3

Pres

3

+

+

3+

10

11

65

1.4

3

7

2

Pres

3

 

5

12

47

6

3

5

2

Pres

3

3+

5

13

45

4.1

2

9

2

Pres

2

+

+

2+

10

14

52

3.5

2

5

2

Abs

2

+

+

0

10

15

79

3.7

1

3

1

Abs

2

+

+

0

5

16

57

4

2

8

2

Pres

1

+

3+

0

17

60

4

1

1

1

Abs

1

+

2+

0

18

53

4

1

1

1

Pres

3

+

+

0

0

19

69

3.5

2

3

1

Pres

3

+

+

0

0

20

56

3

2

2

1

Pres

1

+

+

1+

0

21

68

4

2

7

2

Abs

2

+

0

0

  1. hpf=high power fields; pres=present; abs=absent; LVI=lymphovascular invasion; LN=lymph node; ER=estrogen receptor; PR=progesterone receptor; NA=not available. Cases 1–9: high proliferative activity; cases 10–15: low proliferative activity; cases 16–21: no Ki67 immunostaining.